Key Financial Data Of Group

CHUGAI PHARMACEUTICAL CO., LTD. - Filing #7541828

Concept As at
2023-09-30
2023-07-01 to
2023-09-30
2023-01-01 to
2023-09-30
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-09-30
2022-07-01 to
2022-09-30
2022-01-01 to
2022-09-30
Key financial data of group
Business results of group
Revenue
257,897,000,000 JPY
837,555,000,000 JPY
1,259,726,000,000 JPY
225,284,000,000 JPY
821,231,000,000 JPY
Profit (loss) before tax
321,131,000,000 JPY
531,166,000,000 JPY
381,950,000,000 JPY
Profit (loss)
77,573,000,000 JPY
234,266,000,000 JPY
374,429,000,000 JPY
67,797,000,000 JPY
271,950,000,000 JPY
Profit (loss), attributable to owners of parent
234,266,000,000 JPY
374,429,000,000 JPY
271,950,000,000 JPY
Comprehensive income
241,810,000,000 JPY
373,935,000,000 JPY
258,250,000,000 JPY
Comprehensive income, attributable to owners of parent
241,810,000,000 JPY
373,935,000,000 JPY
258,250,000,000 JPY
Total assets
1,817,649,000,000 JPY
1,869,758,000,000 JPY
1,700,818,000,000 JPY
Basic earnings (loss) per share
47.15
142.40
227.64
41.21
165.35
Diluted earnings (loss) per share
142.37
227.57
165.29
Ratio of owners' equity to gross assets
0.844 xbrli:pure
0.762 xbrli:pure
0.769 xbrli:pure
Cash flows from (used in) operating activities
285,715,000,000 JPY
243,582,000,000 JPY
270,585,000,000 JPY
Cash flows from (used in) investing activities
-42,934,000,000 JPY
-145,465,000,000 JPY
-123,449,000,000 JPY
Cash flows from (used in) financing activities
-137,031,000,000 JPY
-145,641,000,000 JPY
-143,286,000,000 JPY
Cash and cash equivalents
331,341,000,000 JPY
222,169,000,000 JPY
274,043,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.